TORBAY PHARMA
Live / Registered — Registered (as of 16 Dec 2025)
What this means for you
Registered since 16 Dec 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Dec 2031: the §71 affidavit of use).
Record
- Serial number
- 79407751
- Registration number
- 8064008
- Mark type
- Word mark
- Filed
- 03 Jun 2024
- Published for opposition
- 28 Oct 2025
- Registered
- 16 Dec 2025
- Next maintenance filing
- §71 affidavit of use, due by 16 Dec 2031 (grace period to 16 Jun 2032)
- Attorney of record
- Joseph V. Norvell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; injectable pharmaceuticals for the treatment of relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; drug delivery agents in the form of sterilized generic injectables that facilitate the delivery of pharmaceutical preparations.
Owner
Prosecution history
- 16 Jul 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Jun 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Jun 2026 — FINAL DISPOSITION PROCESSED
- 09 Apr 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 16 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Oct 2025 — PUBLISHED FOR OPPOSITION
- 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE